Genmab — Maj 2025
-
Die AbbVie-Aktie könnte bald neuen Rückenwind aus dem Onkologie-Portfolio erhalten. Denn Partner Genmab präsentiert auf der diesjährigen ASCO-Konferenz bahnbrechende Langzeitdaten zu Epcoritamab https://www.aktiencheck.de/news/Artikel-AbbVie_Aktie_Beeindruckende_Ertragserhoehung-18589388
-
Shicheng Guo
@ShihchengGuo
New from Stanford & Genmab: UniTox uses GPT-4o to extract drug-induced toxicities from 2,400+ FDA labels into a structured dataset. https://x.com/ShihchengGuo/status/1926138781318385917 -
a bit more on - Insourcing Cell-line Development Streamlines Antibody Biomanufacturing - https://www.genengnews.com/topics/bioprocessing/insourcing-cell-line-development-streamlines-antibody-biomanufacturing
-
Genmabs fremtidige salg af epcoritamab https://proinvestor.com/boards/126539
-
GEN1057 moves expected completion dates a year earlier, never really know what it means; either recruitment is going superfast or patients can stay on the drug much shorter as anticipated... anyway, we'll know earlier https://clinicaltrials.gov/study/NCT06573294?tab=history&a=7&b=8#version-content-panel
-
Abbvie arbejder med nye payloads med bedre virkning deres allerede godkendte EMRELIS
(telisotuzumab vedotin-tllv). Nyt stof ABBV-
400 (Telisotuzumab adizutecan) er værd at følge https://news.abbvie.com/2025-05-27-AbbVie-Features-New-Data-Across-Difficult-to-Treat-Solid-Tumors-and-Blood-Cancers-at-ASCO-2025,-Highlighting-Breadth-and-Depth-of-its-Oncology-Portfolio -
ABBV-400 stammer fra Immunogen købet til $10bn. ABBV-400 har DAR 6 og artiklen der er linket til nævner SAE som noget vi skal holde øje med https://www.oncologypipeline.com/apexonco/asco-2024-preview-jury-still-out-abbvies-cancer-push Husk at Elahere som også kommer fra nævnte køb også har problematiske SAE (2% fatale). Rina-S er konkurrent til Elahere. Sandelig spændende for Abbvie

-
Maj Status: NVIDIA, toldsatser, Novo, Zealand Pharma, Gubra, Genmab, Embla Kort video: https://proinvestor.com/boards/126575
-
Godmorgen

Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind